Little Rock, AR, United States of America

Bart Barlogie

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 161(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Bart Barlogie in Multiple Myeloma Research**

Introduction

Bart Barlogie, based in Little Rock, AR, has made significant contributions to the field of medical research, particularly focused on multiple myeloma. With an impressive portfolio of 19 patents, he combines innovative methods with cutting-edge research to enhance prognostic capabilities and treatment regimens for patients. His work is instrumental in understanding and combating this complex disease.

Latest Patents

One of Barlogie's most notable inventions is the GEP5 model for multiple myeloma. This groundbreaking patent addresses methods for prognosing individuals who are suspected of having multiple myeloma. The invention emphasizes the importance of genetic markers, outlining methods that involve the testing of gene expression levels for enolase 1 (ENO1), fatty acid binding protein 5 (FABP5), thyroid hormone receptor interactor 13 (TRIP13), transgelin 2 (TAGLN2), and replication factor C (activator 1) 4 (RFC4) in biological samples. Furthermore, it encompasses treatment methodologies for multiple myeloma, as well as accompanying kits, oligonucleotides, and systems designed to implement these methods effectively.

Career Highlights

Throughout his career, Bart Barlogie has been associated with esteemed institutions, including the University of Arkansas and Bioventures, LLC. His experiences in these organizations have provided him with a platform to further his research and apply his inventions in practical settings, positively impacting the development of therapeutic approaches for multiple myeloma.

Collaborations

Collaboration plays a crucial role in Barlogie's research endeavors. He has worked alongside renowned colleagues such as John D. Shaughnessy and Fenghuang Zhan. These partnerships have fostered a rich exchange of ideas and facilitated advancements in treatment methodologies for patients suffering from multiple myeloma.

Conclusion

Bart Barlogie's innovative contributions to multiple myeloma research showcase his commitment to improving patient outcomes through science and technology. His extensive patent portfolio reflects a career dedicated to advancing medical knowledge and treatment solutions. The implications of his work continue to be felt in the medical community, paving the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…